Akoya Biosciences Inc.

NASDAQ: AKYA · Real-Time Price · USD
1.29
-0.07 (-5.15%)
At close: Jul 07, 2025, 3:59 PM

Akoya Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-55.37M -63.32M -70.64M -42.94M
Depreciation & Amortization
7.65M 8.89M 7.15M 4.79M
Stock-Based Compensation
9.31M 10.44M 7.43M 4.04M
Other Working Capital
-3.31M -2.03M 6.63M -1.32M
Other Non-Cash Items
8.18M 7.63M 367K 2.75M
Deferred Income Tax
4K -51K 35K -155K
Change in Working Capital
-13.88M -14.48M 2.16M -4.56M
Operating Cash Flow
-44.1M -50.9M -53.5M -36.07M
Capital Expenditures
-2.46M -3.65M -7.36M -5.09M
Cash Acquisitions
n/a n/a 55K n/a
Purchase of Investments
-104.29M n/a -40.77M n/a
Sales Maturities Of Investments
82.7M 7M 34M n/a
Other Investing Acitivies
n/a n/a -6.72M n/a
Investing Cash Flow
-24.05M 3.35M -14.08M -5.09M
Debt Repayment
-1.02M 10.57M 30.63M -322K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a -1.44M
Other Financial Acitivies
-2.18M -1.7M -1.9M 239K
Financial Cash Flow
-3.21M 56.84M 28.73M 137.03M
Net Cash Flow
-71.36M 9.29M -38.85M 95.87M
Free Cash Flow
-46.56M -54.55M -60.86M -41.16M